News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Optimer Pharmaceuticals, Inc. (OPTR) Reports First Quarter 2013 Financial Results


5/10/2013 6:28:37 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

JERSEY CITY, N.J., May 9, 2013 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced today unaudited financial results for the first quarter ended March 31, 2013.

Financial Highlights

•First quarter 2013 DIFICID net product sales in the U.S. and Canada of $16.8 million, compared to $14.4 million in 2012

Help employers find you! Check out all the jobs and post your resume.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES